Martina Mirlacher
Roche (Switzerland)(CH)Universität Hamburg(DE)Pfizer (United States)(US)International Drug Development Institute (Belgium)(BE)AstraZeneca (Brazil)(BR)Ventana Research Corporation (United States)(US)Puma Biotechnology (United States)(US)International Drug Development(FR)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Gene expression and cancer classification, Molecular Biology Techniques and Applications, Cell Adhesion Molecules Research
Most-Cited Works
- → Frequent EpCam protein expression in human carcinomas(2004)821 cited
- → High-Throughput Tissue Microarray Analysis to Evaluate Genes Uncovered by cDNA Microarray Screening in Renal Cell Carcinoma(1999)395 cited
- → Prognostic Relevance of Gene Amplifications and Coamplifications in Breast Cancer(2004)348 cited
- → Arterial Neovascularization and Inflammation in Vulnerable Patients(2004)347 cited
- → Diagnostic Evaluation of HER-2 as a Molecular Target: An Assessment of Accuracy and Reproducibility of Laboratory Testing in Large, Prospective, Randomized Clinical Trials(2005)310 cited
- → High Ep-CAM Expression is Associated with Poor Prognosis in Node-positive Breast Cancer(2004)257 cited